Integra LifeSciences Holdings (IART)

Return on assets (ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	67,741	180,550	169,075	133,892	50,201
Total assets	US$ in thousands	3,781,990	3,889,760	3,782,380	3,615,140	3,303,240
ROA		1.79%	4.64%	4.47%	3.70%	1.52%

December 31, 2023 calculation

ROA = Net income ÷ Total assets
= $67,741K ÷ $3,781,990K
= 1.79%

Integra Lifesciences Holdings Corp's return on assets (ROA) has fluctuated over the past five years, indicating varying levels of efficiency in generating profits from its assets. The ROA decreased from 4.47% in 2021 to 3.70% in 2020, suggesting a slight decline in the company's ability to generate profit relative to its assets during that period. However, the ROA increased to 4.64% in 2022, indicating improved efficiency in asset utilization.

In the most recent year, Dec 31, 2023, the ROA further declined to 1.79%, signaling a significant decrease in the company's profitability relative to its assets compared to the previous year. This drop may raise concerns about the company's asset efficiency and the effectiveness of its operations in generating returns for shareholders.

Overall, while Integra Lifesciences Holdings Corp's ROA has shown some volatility, it is essential for stakeholders to closely monitor trends in this ratio to assess the company's operational performance and asset utilization efficiency.